风险因素的修改,以防止在导管切除后的复发性心房动
Jack Hartnett1, Nour Chouman2, Eoin Donnellan2
1Department of Cardiology, Mater Misericordiae University Hospital, Dublin, Ireland jhartne@tcd.ie.
Cleveland Clinic journal of medicine
|January 2, 2025
概括
对心房动的导管切除具有很高的复发率. 在切除前修改高血压和肥胖等危险因素可以改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 预防医学 预防医学
背景情况:
- 导管切除是对心房动的常见节律控制策略.
- 废除后的高复发率需要改进长期管理.
- 许多风险因素有助于心房的发展和持续.
研究的目的:
- 审查新出现的证据,以修改周周形成的风险因素.
- 为了优化用于心房动的导管切除后的结果.
主要方法:
- 对研究风险因素和废除结果的文献综述.
- 综合证据对修改高血压,糖尿病,脂质失调,肥胖,阻塞性睡眠呼吸暂停,代谢功能障碍相关的脂肪性肝病 (MASLD),吸烟,酒精消费和身体不活动的影响.
主要成果:
- 新出现的证据表明,应对可修改的危险因素 (periablation) 可以显著影响复发率.
- 针对高血压,糖尿病和肥胖等疾病的具体干预措施在提高切除成功方面表现有前途.
结论:
- 修改置风险因子是一个关键的策略,以提高对心房动的导管切除后的长期成功.
- 针对潜在风险因素的综合患者管理对于优化节律控制至关重要.
相关概念视频
Disturbances in Heart Rhythm
699
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
699
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
636
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
636
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
299
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
299
Mechanism of Cardiac Arrhythmias
847
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
847


